BRCA1 promoter methylation in peripheral blood cells and predisposition to breast cancer.
Open Access
- 1 June 2017
- journal article
- review article
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 12 (3) , 189-193
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Altered Plasma Apolipoprotein Modifications in Patients with Pancreatic Cancer: Protein Characterization and Multi-Institutional ValidationPLOS ONE, 2012
- Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free womenInternational Journal of Oncology, 2011
- Expression of IGF1R in normal breast tissue and subsequent risk of breast cancerBreast Cancer Research and Treatment, 2011
- Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast CancerCancer Prevention Research, 2011
- Hereditary breast cancer: new genetic developments, new therapeutic avenuesHuman Genetics, 2008
- BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1tumour phenotypeBreast Cancer Research, 2008
- Characterization of apolipoprotein and apolipoprotein precursors in pancreatic cancer serum samples via two-dimensional liquid chromatography and mass spectrometryJournal of Chromatography A, 2007
- Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumoursEuropean Journal of Cancer, 2007
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- Hereditary breast cancer: a reviewSeminars in Cancer Biology, 2000